Biofrontera AG | CIK:0001712641 | 3

  • Filed: 4/30/2018
  • Entity registrant name: Biofrontera AG (CIK: 0001712641)
  • Generator: Novaworks Software
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1712641/000149315218005915/0001493152-18-005915-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1712641/000149315218005915/bfra-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001712641
  • Open this page in separate window: Click
  • ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory

    Financial instruments

     

    The financial instruments held by the Biofrontera Group on the balance sheet date primarily consist of cash and cash equivalents, trade payables and receivables as well as financial debt. Biofrontera does not deploy any financial derivatives, apart from the derivative embedded within the EIB loan (so-called performance component). Due to the short terms of the trade payables and trade receivables, the carrying amounts of such items correspond to their fair values. The remaining related receivables and liabilities are classified to “Other Assets” or “Other Provisions”, respectively. The financial liabilities are measured applying the effective interest method.